PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 128 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is 1.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $606,000 | -12.7% | 62,300 | -8.0% | 0.00% | -100.0% |
| Q4 2020 | $694,000 | -0.3% | 67,686 | -1.9% | 0.00% | 0.0% |
| Q3 2020 | $696,000 | -0.7% | 68,986 | +2.7% | 0.00% | 0.0% |
| Q2 2020 | $701,000 | +20.2% | 67,186 | -2.7% | 0.00% | 0.0% |
| Q1 2020 | $583,000 | +1.4% | 69,042 | +5.1% | 0.00% | 0.0% |
| Q4 2019 | $575,000 | -18.7% | 65,700 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $707,000 | -2.6% | 65,700 | +15.1% | 0.00% | 0.0% |
| Q2 2019 | $726,000 | -67.5% | 57,100 | -0.9% | 0.00% | -66.7% |
| Q1 2019 | $2,234,000 | +85.4% | 57,600 | -2.7% | 0.00% | +50.0% |
| Q4 2018 | $1,205,000 | -59.5% | 59,200 | -8.8% | 0.00% | -50.0% |
| Q3 2018 | $2,976,000 | -28.4% | 64,900 | -7.7% | 0.00% | -33.3% |
| Q2 2018 | $4,158,000 | -42.0% | 70,300 | -33.2% | 0.01% | -40.0% |
| Q1 2018 | $7,166,000 | -36.1% | 105,300 | -7.3% | 0.01% | -33.3% |
| Q4 2017 | $11,223,000 | -13.2% | 113,533 | +5.1% | 0.02% | -21.1% |
| Q3 2017 | $12,933,000 | +38.0% | 108,000 | +0.7% | 0.02% | +26.7% |
| Q2 2017 | $9,369,000 | +140.1% | 107,200 | +2.2% | 0.02% | +150.0% |
| Q1 2017 | $3,902,000 | +16.1% | 104,900 | -4.2% | 0.01% | 0.0% |
| Q4 2016 | $3,362,000 | +26.9% | 109,500 | +177.2% | 0.01% | +50.0% |
| Q3 2016 | $2,649,000 | +109.7% | 39,500 | -6.8% | 0.00% | +100.0% |
| Q2 2016 | $1,263,000 | -1.8% | 42,400 | -3.2% | 0.00% | 0.0% |
| Q1 2016 | $1,286,000 | -64.7% | 43,800 | -5.8% | 0.00% | -66.7% |
| Q4 2015 | $3,646,000 | +4.1% | 46,500 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $3,504,000 | -35.5% | 46,500 | 0.0% | 0.01% | -25.0% |
| Q2 2015 | $5,429,000 | -51.2% | 46,500 | -5.4% | 0.01% | -46.7% |
| Q1 2015 | $11,115,000 | 0.0% | 49,155 | 0.0% | 0.02% | 0.0% |
| Q4 2014 | $11,115,000 | -4.7% | 49,155 | +0.5% | 0.02% | -6.2% |
| Q3 2014 | $11,669,000 | +280.2% | 48,914 | +5.2% | 0.02% | +300.0% |
| Q2 2014 | $3,069,000 | -22.9% | 46,500 | -5.5% | 0.00% | -33.3% |
| Q1 2014 | $3,979,000 | +8189.6% | 49,215 | +5368.3% | 0.01% | – |
| Q3 2013 | $48,000 | – | 900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,300,000 | $12,636,000 | 2.61% |
| AIGH Capital Management LLC | 964,590 | $9,376,000 | 1.97% |
| Worth Venture Partners, LLC | 226,758 | $2,204,000 | 1.07% |
| Camber Capital Management LP | 2,555,000 | $24,835,000 | 0.85% |
| Palo Alto Investors LP | 1,392,997 | $13,540,000 | 0.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,769,795 | $36,642,000 | 0.77% |
| GLOBEFLEX CAPITAL L P | 428,680 | $4,167,000 | 0.76% |
| Zebra Capital Management LLC | 34,243 | $333,000 | 0.37% |
| Sofinnova Investments, Inc. | 344,917 | $3,353,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 605,792 | $5,888,000 | 0.19% |